Gene expression profiling of myeloma cells to predict response to primary therapy with thalidomide. Dexamethasone for newly diagnosed multilple myeloma

被引：0

作者：

Abdelkefi, Abderrahman ^{[1
]}

de Vos, John ^{[2
]}

Assou, Said ^{[2
]}

Ben Othman, Tarek ^{[1
]}

Rossi, Jean-Francois ^{[3
]}

Ladeb, Saloua ^{[1
]}

Safra, Ines ^{[4
]}

Galai, Yosr ^{[4
]}

Ben Ahmed, Malika ^{[4
]}

Benkahla, Alia ^{[4
]}

Jenhani, Faouzi ^{[5
]}

Ben Nasr, Moufida ^{[5
]}

Torjman, Lamia ^{[1
]}

Lakhal, Amel ^{[1
]}

Louzir, Hechim ^{[4
]}

Ben Abdeladhim, Abdeladhim ^{[1
]}

机构：

[1] Ctr Natl Greffe Moelle Osseuse, Tunis, Tunisia

[2] Hop St Eloi, Lab Transcriptome, IRB, Montpellier, France

[3] Hop Lapeyronie, Serv Onco Hematol, Montpellier, France

[4] Inst Pasteur, Tunis, Tunisia

[5] Ctr Natl Transfus Sanguine, Tunis, Tunisia

来源：

BLOOD | 2007年 / 110卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1494

引用

页码：447A / 447A

页数：1

共 50 条

[1] Gene expression profiling of myeloma cells at diagnosis can predict response to therapy with thalidomide and dexamethasone combination.
Kumar, S
Greipp, PR
Haug, J
Kline, M
Chng, WJ
Blood, E
Bergsagel, L
Lust, JA
Gertz, MA
Fonseca, R
Rajkumar, SV
[J]. BLOOD, 2005, 106 (11) : 152A - 152A
[2] Prediction of response to primary therapy with thalidomide-dexamethasone(Thal-DEX) for newly diagnosed multiple myeloma by gene expression profiling (GEP)
Terragna, C.
Renzulli, M.
Remondini, D.
Tagliafico, E.
Roncaglia, E.
Tosi, P.
Zamagni, E.
Tacchetti, P.
Perrone, G.
Ceccolini, M.
Brioli, A. M.
Martinelli, G.
Baccarani, M.
Cavo, M.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 177 - 177
[3] Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by Gene Expression Profiling (GEP)
Terragna, C.
Renzulli, M.
Remondini, D.
Tagliafico, E.
Roncaglia, E.
Tosi, P.
Zamagni, E.
Tacchetti, P.
Perrone, G.
Ceccolini, M.
Brioli, A.
Pallotti, M. C.
Martinelli, G.
Baccarani, M.
Cavo, M.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 138 - 138
[4] Gene expression profiling (GEP) of myeloma (MM) cells to predict attainment (near) complete response to primary therapy with thalidomide-dexamethasone (thali-dex) for newly diagnosed MM.
Terragna, Carolina
Renzulli, M.
Remondini, D.
Tagliafico, E.
Roncaglia, E.
Tosi, P.
Zamagni, E.
Tacchetti, P.
Perrone, G.
Ceccolini, M.
Martinelli, Giovanni
Baccarani, M.
Cavo, M.
[J]. BLOOD, 2006, 108 (11) : 76A - 77A
[5] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
Meletios A Dimopoulos
Efstathios Kastritis
[J]. Nature Clinical Practice Oncology, 2008, 5 : 690 - 691
[6] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
Dimopoulos, Meletios A.
Kastritis, Efstathios
[J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 690 - 691
[7] Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
Rajkumar, SV
Hayman, S
Gertz, MA
Dispenzieri, A
Lacy, MQ
Greipp, PR
Geyer, S
Iturria, N
Fonseca, R
Lust, JA
Kyle, RA
Witzig, TE
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) : 4319 - 4323
[8] Thalidomide plus dexamethasone for newly diagnosed myeloma
Lindsey, H
[J]. LANCET ONCOLOGY, 2002, 3 (12): : 711 - 711
[9] Thalidomide and dexamethasone in newly diagnosed multiple myeloma.
McHugh, Johnny
O'Ceallaigh, Cathal
Keane, Colm
Otridge, Brian W.
O'Gorman, Peter
[J]. BLOOD, 2006, 108 (11) : 370B - 370B
[10] VTD (velcade, thalidomide, dexamethasone) as primary therapy for newly-diagnosed multiple myeloma.
Alexaman, R
Wang, LM
Weber, DM
Delasalle, KB
[J]. BLOOD, 2004, 104 (11) : 64A - 64A

← 1 2 3 4 5 →